1. Home
  2. KALA vs TCMD Comparison

KALA vs TCMD Comparison

Compare KALA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.36

Market Cap

319.6M

Sector

Health Care

ML Signal

N/A

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

N/A

Current Price

$27.86

Market Cap

300.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KALA
TCMD
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
300.1M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
KALA
TCMD
Price
$0.36
$27.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$31.50
$36.00
AVG Volume (30 Days)
731.1K
400.5K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
41.50
17.14
EPS
N/A
0.82
Revenue
N/A
N/A
Revenue This Year
N/A
$11.60
Revenue Next Year
N/A
$9.14
P/E Ratio
N/A
$34.26
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$8.61
52 Week High
$20.58
$37.77

Technical Indicators

Market Signals
Indicator
KALA
TCMD
Relative Strength Index (RSI) 45.33 44.63
Support Level $0.35 $26.47
Resistance Level $0.72 $30.74
Average True Range (ATR) 0.05 1.18
MACD 0.00 -0.14
Stochastic Oscillator 70.79 26.35

Price Performance

Historical Comparison
KALA
TCMD

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Share on Social Networks: